IDENTIFICATION OF NEW BIOMARKERS FOR CARDIAC DISORDERS EXPLOITING TISSUE-SPECIFIC METHYLATION PATTERN OF CIRCULATING FREE DNA: A PILOT STUDY


Article ID: 6474
Vol 32, Issue 4S1, 2018
DOI: https://doi.org/10.54517/jbrha6474
Received: 8 September 2018; Accepted: 8 September 2018; Available online: 8 September 2018; Issue release: 8 September 2018

Abstract

Cardiomyopathies are a group of diseases leading to adverse outcome. Due to clinical heterogeneity andphenotypic overlapping, the identification of specific non-invasive diagnostic and prognostic markerscan be useful and remains a challenge. Our aim is to exploit cardiac cfDNA as new cardiac biomarkerbased on the following assumptions: i) methylation patterns are unique and conserved in a specifictissue, hence their analysis could be used to identify the tissue of origin of circulating cell free DNA(cfDNA); ii) cfDNA levels of cardiac origin may be higher in the presence of cardiac disorder.



References

Supporting Agencies



Copyright (c) 2018




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).